This site is sponsored by an unrestricted educational grant from Pierre Fabre Médicament

Neuropsychiatric Disease and Treatment

Neuropsychiatic Disease and Treatment provides a unique forum where neurology meets psychiatry. It encourages both experimental and clinical research. It has a distinguished Editorial Board, and peer review standards are high. The Commentary and Expert opinion sections of the journal allow people to express sometimes controversial views which are not always associated with the more traditional review and original research articles.

Roger M Pinder - Founding Editor

Neuropsychiatric Disease and Treatment

2016 Volume 12

All articles in volume 12 (2016)
All articles in volume 11 (2015)

Selected recent papers

With the adoption of OPEN ACCESS the journal has abandoned the concept of monthly issues and publishes papers online as soon as they are available. highlights recent papers of particular interest to psychiatrists
and neuroscientists as soon as they appear on line

The full text of all papers are now freely available online through OPEN ACCESS.
Click on the titles to access the abstracts and then the full text.



Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
Kurita M
Neuropsychiatric Disease and Treatment 2016, 12:2373-2380


Original Research

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, Li P, Zhou X, Zhang Y, Liu Y, Xie P
Neuropsychiatric Disease and Treatment 2016, 12:2859-2867


Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
Huang Q, Zhong X, Yun Y, Yu B, Huang Y
Neuropsychiatric Disease and Treatment 2016, 12:2707-2714


Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study
Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M
Neuropsychiatric Disease and Treatment 2016, 12:2677-2687


Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction
Tian XQ, Wang Q, Guo R, Xu LL, Chen QM, Hou YL
Neuropsychiatric Disease and Treatment 2016, 12:2333-2341



Exercise is medicine for depression: even when the “pill” is small
Hallgren M, Vancampfort D, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:2715-2721

Updated December 2016

Follow this link for further information on this journal, instructions to authors and more articles

Site conceived and produced by NeuroBiz Consulting & Communications
Copyright © Mike Briley & Chantal Moret, 2016


shopify traffic stats